Articles published by Magnus Medical, Inc.

Magnus Medical Announces Uninterrupted 2026 Payment Stability for SAINT Neuromodulation in CMS OPPS Final Rule

November 24, 2025

From Magnus Medical, Inc.

Via Business Wire

Magnus Medical Announces CMS Approval of New Payment Rate for SAINT Treatment in 2025 Hospital Outpatient Rule

November 12, 2024

From Magnus Medical, Inc.

Via Business Wire

Magnus Medical Highlights New Clinical Data on Groundbreaking SAINT Therapy at 2024 NYC Neuromodulation Conference

August 01, 2024

From Magnus Medical, Inc.

Via Business Wire

Magnus Medical Announces Commercial Launch of Groundbreaking SAINT Neuromodulation System

April 30, 2024

From Magnus Medical, Inc.

Via Business Wire

Magnus Medical Announces American Medical Association Issues New CPT Category III Codes for Targeted, Accelerated Intermittent Theta-Burst Stimulation

October 23, 2023

From Magnus Medical, Inc.

Via Business Wire

Magnus Medical Announces First Participants Treated in Study Using SAINT Neuromodulation System for Major Depression

July 20, 2023

From Magnus Medical, Inc.

Via Business Wire

Magnus Medical Shares New Study Results That Find Treatment With SAINT for Severe Depression Changes Abnormal Brain Signals

May 15, 2023

From Magnus Medical, Inc.

Via Business Wire

Magnus Medical Receives FDA Clearance for the SAINT Neuromodulation System for Non-Invasive, Individualized and Precise Treatment of Severe Depression

September 06, 2022

From Magnus Medical, Inc.

Via Business Wire

Magnus Medical Launches With Breakthrough Device Designation for Rapid, Individualized Treatment of Major Depression and $25M in Series A Financing

October 29, 2021

From Magnus Medical, Inc.

Via Business Wire

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.